2026 Q1 -tulosraportti
Vain PDF
65 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·23 t sittenI only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/I have invested approx. 1/2 of my money in Stenocare and the other in Bioporto. I don't want to miss out when the stock starts to rise. No, I don't dare to give a price, because if it's pure analysis, they probably say 1.75 kr. but they also haven't included that business is booming in Germany. I was in the middle of a pointless calculation. I'll spare you that. There will be an upward adjustment. If people shrug their shoulders, the price will fall, but if people notice this upward adjustment and want to join in, the price will rise. Therefore, I won't make a guess, as I can't figure out what people will do when SC comes with this positive announcement, that there is much more sales than expected in Germany. It's only because I've been on the heels of Weeco Pharma, and have been able to ascertain that business is booming in Germany, that I have bet 1/2, of the business, on this stock,- ·6.7.A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
·6.7.This is falling and falling, it's certainly a hopeless case.10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?- ·3.7.STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
Vain PDF
65 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sittenI only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/I have invested approx. 1/2 of my money in Stenocare and the other in Bioporto. I don't want to miss out when the stock starts to rise. No, I don't dare to give a price, because if it's pure analysis, they probably say 1.75 kr. but they also haven't included that business is booming in Germany. I was in the middle of a pointless calculation. I'll spare you that. There will be an upward adjustment. If people shrug their shoulders, the price will fall, but if people notice this upward adjustment and want to join in, the price will rise. Therefore, I won't make a guess, as I can't figure out what people will do when SC comes with this positive announcement, that there is much more sales than expected in Germany. It's only because I've been on the heels of Weeco Pharma, and have been able to ascertain that business is booming in Germany, that I have bet 1/2, of the business, on this stock,
- ·6.7.A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
- ·6.7.This is falling and falling, it's certainly a hopeless case.10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?
- ·3.7.STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
Vain PDF
65 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sittenI only discovered this today. Weeco Pharma has been at the EU's largest cannabis fair for professionals such as pharmacists and dealers. Weeco Astrum10-10 was part of their campaign already at the fair, which may be the reason why it has been possible for Weeco Pharma that so many doctors, in such a short time, have become aware of the oil. https://weeco.com/en/2026/02/13/weeco-will-be-present-at-the-icbc-in-berlin-on-april-13th-and-15th/I have invested approx. 1/2 of my money in Stenocare and the other in Bioporto. I don't want to miss out when the stock starts to rise. No, I don't dare to give a price, because if it's pure analysis, they probably say 1.75 kr. but they also haven't included that business is booming in Germany. I was in the middle of a pointless calculation. I'll spare you that. There will be an upward adjustment. If people shrug their shoulders, the price will fall, but if people notice this upward adjustment and want to join in, the price will rise. Therefore, I won't make a guess, as I can't figure out what people will do when SC comes with this positive announcement, that there is much more sales than expected in Germany. It's only because I've been on the heels of Weeco Pharma, and have been able to ascertain that business is booming in Germany, that I have bet 1/2, of the business, on this stock,
- ·6.7.A little statistics while we wait for Weeco to get signed with Stenocare. In 2025, more than 6,900 liters of cannabis oils and extracts were sold, and it is expected that this will be increasing in 2026. When I have this converted to 30 ml bottles, with the help of AI, it amounts to 230,000 bottles in 2025. Bearing in mind that the subsidy is taken from flowers and vaporizers, https://www.insight-health.de/deu_en/our-solututions/specialty-therapeutics/medical-cannabis.html
- ·6.7.This is falling and falling, it's certainly a hopeless case.10 k in turnover today, is it a sinking ship? Is it just a matter of getting out before the ship sinks?
- ·3.7.STENOCARE completes the integration of CannGros ApS Fri, 3. July 2026 19:37 CETReport this content STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DANMARK TICKER: STENO STENOCARE A/S (“STENOCARE”) is pleased to announce that the integration of CannGros ApS, which was acquired in November 2025, has now been successfully completed by the end of June 2026. The integration of CannGros ApS has been completed as planned with several successful import, repackaging and sales processes, the company merger concluded and process optimizations implemented to reduce both costs and delivery time. https://news.cision.com/stenocare/r/stenocare-completes-integration-of-canngros-aps,c4371090I'm not thinking that far ahead with this stock. I take one quarter at a time..management expects 0 kr. in sales from Germany for the entire 2026. See previous link. There will be revenue from Germany, the question is how much, and if it turns out that management can see that they will exceed 13 mill. for 2026 when they are settled with Weeco Pharma, then we should be notified. Even though they say they haven't provided any guidance. I believe there is a probability of an upward revision, since at least 8 platforms have the oil in stock. From now and approx. 14 days ahead, Stenocare will have settled with Weeco Pharma. Maybe I shouldn't blink, so I don't miss the news .😶
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt